title: Optimizing the use of anti-tumor necrosis factor in the management of patients with Crohn's disease.
abstract: Since the approval of the first anti-tumor necrosis factor (anti-TNF) therapy in late 1998, the treatment for Crohn's disease (CD) has been revolutionized. Anti-TNF therapy has been consistently shown in numerous clinical trials to be effective for patients with more aggressive perianal, internal penetrating, and fistulizing CD. However, the loss of clinical remission is frequent and only one-third of patients remain in clinical remission at 1 year. The pharmacokinetics of anti-TNF is highly variable among patients and could be influenced by many factors including serum albumin, gender, body weight, systemic inflammation and route of administration. The main factor impacting anti-TNF pharmacokinetics and efficacy is the development of immunogenicity where antidrug antibodies accelerate anti-TNF drug clearance. In this review paper, we evaluate the role of combination therapy with anti-TNF drugs and immunomodulators, the role of therapeutic drug monitoring, and strategies to recapture loss of clinical response in order to improve both short- and long-term outcomes in CD patients.
authors.affiliation: Department of Medicine, UC Irvine School of Medicine, 333 City Boulevard West, Suite 400 Orange, CA 92868, USA.
authors.forename: Douglas L
authors.initials: DL
authors.lastname: Nguyen
authors.affiliation: Department of Medicine, University of California, Irvine, CA, USA.
authors.forename: Sarah
authors.initials: S
authors.lastname: Flores
authors.affiliation: Department of Medicine, University of California, Irvine, CA, USA.
authors.forename: Kareem
authors.initials: K
authors.lastname: Sassi
authors.affiliation: Department of Medicine, University of Missouri, Columbia, USA.
authors.forename: Matthew L
authors.initials: ML
authors.lastname: Bechtold
authors.affiliation: Department of Pharmacy, University of California, Irvine, CA, USA.
authors.forename: Emily T
authors.initials: ET
authors.lastname: Nguyen
authors.affiliation: Department of Medicine, University of Missouri, Columbia, USA.
authors.forename: Nimisha K
authors.initials: NK
authors.lastname: Parekh
keywords: Crohn’s disease; anti-TNF; inflammatory bowel disease; ulcerative colitis